{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:35:49Z","timestamp":1759638949182},"reference-count":25,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2014.00660","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T15:16:02Z","timestamp":1419002162000},"source":"Crossref","is-referenced-by-count":4,"title":["Targeted Immunology for Prevention and Cure of VL"],"prefix":"10.3389","volume":"5","author":[{"given":"Nahid","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hira L.","family":"Nakhasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus G.","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Barbosa","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,12,19]]},"reference":[{"issue":"4","key":"B1","doi-asserted-by":"publisher","first-page":"e2810","DOI":"10.1371\/journal.pntd.0002810","article-title":"Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinent","volume":"8","author":"Stauch","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"B2","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fimmu.2012.00069","article-title":"Vaccines for canine leishmaniasis","volume":"3","author":"Palatnik-de-Sousa","year":"2012","journal-title":"Front Immunol"},{"issue":"8","key":"B4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3389\/fimmu.2014.00480","article-title":"Deception and manipulation: the arms of Leishmania, a successful parasite","volume":"5","author":"Cecilio","year":"2014","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fimmu.2012.00251","article-title":"Immunobiology of visceral leishmaniasis","volume":"3","author":"Kumar","year":"2012","journal-title":"Front Immunol"},{"issue":"8","key":"B7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1089\/jir.2008.0061","article-title":"Interferon-gamma is induced in human peripheral blood immune cells in vitro by sodium stibogluconate\/interleukin-2 and mediates its antitumor activity in vivo","volume":"29","author":"Fan","year":"2009","journal-title":"J Interferon Cytokine Res"},{"issue":"11","key":"B8","doi-asserted-by":"publisher","first-page":"7146","DOI":"10.4049\/jimmunol.0803859","article-title":"Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response","volume":"182","author":"Wadhone","year":"2009","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fimmu.2014.00296","article-title":"Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects","volume":"5","author":"Singh","year":"2014","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fimmu.2014.00273","article-title":"Leishmania donovani nucleoside hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection","volume":"5","author":"Nico","year":"2014","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fimmu.2014.00272","article-title":"Immunotherapy and immunochemotherapy in visceral Leishmaniasis: promising treatments for this neglected disease","volume":"5","author":"Roatt","year":"2014","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fimmu.2014.00193","article-title":"Exploring the role of medicinal plant-based immunomodulators for effective therapy of leishmaniasis","volume":"5","author":"Chouhan","year":"2014","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fimmu.2014.00380","article-title":"Visceral Leishmaniasis: advancements in vaccine development via classical and molecular approaches","volume":"5","author":"Joshi","year":"2014","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fimmu.2014.00189","article-title":"Cross-protective immunity to Leishmania amazonensis is mediated by CD4+ and CD8+ epitopes of Leishmania donovani nucleoside hydrolase terminal domains","volume":"5","author":"Nico","year":"2014","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fimmu.2014.00260","article-title":"Leishmania spp. proteome data sets: a comprehensive resource for vaccine development to target visceral leishmaniasis","volume":"5","author":"Aebischer","year":"2014","journal-title":"Front Immunol"},{"issue":"234","key":"B16","doi-asserted-by":"publisher","first-page":"234ra56","DOI":"10.1126\/scitranslmed.3008222","article-title":"Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis","volume":"6","author":"Das","year":"2014","journal-title":"Sci Transl Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fimmu.2014.00268","article-title":"Experimental validation of multi-epitope peptides including promising MHC class I- and II-restricted epitopes of four known Leishmania infantum proteins","volume":"5","author":"Agallou","year":"2014","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fimmu.2014.00261","article-title":"Antigen-pulsed CpG-ODN-activated dendritic cells induce host-protective immune response by regulating the t regulatory cell functioning in Leishmania donovani-infected mice: critical role of CXCL10","volume":"5","author":"Majumder","year":"2014","journal-title":"Front Immunol"},{"issue":"4845","key":"B19","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1126\/science.3344436","article-title":"Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity","volume":"239","author":"Titus","year":"1988","journal-title":"Science"},{"issue":"12","key":"B20","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1038\/jid.2012.205","article-title":"Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted Leishmania conferring ulcer-free protection","volume":"132","author":"Gomes","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"22","key":"B21","doi-asserted-by":"publisher","first-page":"7845","DOI":"10.1073\/pnas.0712153105","article-title":"Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model","volume":"105","author":"Gomes","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fpubh.2014.00099","article-title":"Vector saliva in vaccines for visceral leishmaniasis: a brief encounter of high consequence?","volume":"2","author":"Kamhawi","year":"2014","journal-title":"Front Public Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fimmu.2014.00134","article-title":"Live vaccination tactics: possible approaches for controlling visceral leishmaniasis","volume":"5","author":"Saljoughian","year":"2014","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fimmu.2014.00213","article-title":"Genetically modified organisms and visceral leishmaniasis","volume":"5","author":"Chhajer","year":"2014","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fimmu.2014.00241","article-title":"Biomarkers of safety and immune protection for genetically modified live attenuated Leishmania vaccines against visceral leishmaniasis \u00e2\u20ac\u201c discovery and implications","volume":"5","author":"Gannavaram","year":"2014","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T20:30:04Z","timestamp":1424291404000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2014.00660\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,19]]},"references-count":25,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2014.00660","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,19]]}}}